25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?

Erin D. Michos, Pamela L. Lutsey

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of '25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?'. Together they form a unique fingerprint.